NCT05923632 The Effect Of Model-Based Dıgıtal Game On Metabolıc Control, Self-Effıcıency And Qualıty Of Lıfe In Chıldren Wıth Type 1 Dıabetes
| NCT ID | NCT05923632 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abant Izzet Baysal University |
| Condition | Type 1 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 58 participants |
| Start Date | 2024-11-20 |
| Primary Completion | 2025-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 58 participants in total. It began in 2024-11-20 with a primary completion date of 2025-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was planned to determine the effect of model-based digital game on metabolic control, self-efficacy and quality of life in children with T1DM.
Eligibility Criteria
Inclusion Criteria: * Being in the 8-13 age range, * Being diagnosed with T1DM at least 6 months ago, * Ability to read and write Turkish, * Ability to communicate verbally, * To have Internet access, * Computer, tablet, etc. to have and use technological tools, * To volunteer to participate in the study Exclusion Criteria: • Having another chronic disease other than T1DM
Contact & Investigator
Bedriye AK, Associate Prof.Dr.
STUDY DIRECTOR
Abant Izzet Baysal University
Frequently Asked Questions
Who can join the NCT05923632 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 13 Years, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05923632 currently recruiting?
Yes, NCT05923632 is actively recruiting participants. Contact the research team at bedriye_ak@yahoo.com for enrollment information.
Where is the NCT05923632 trial being conducted?
This trial is being conducted at Bolu, Turkey (Türkiye), Zonguldak, Turkey (Türkiye).
Who is sponsoring the NCT05923632 clinical trial?
NCT05923632 is sponsored by Abant Izzet Baysal University. The principal investigator is Bedriye AK, Associate Prof.Dr. at Abant Izzet Baysal University. The trial plans to enroll 58 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.